Biophan Technologies, Inc. announced today that it will present at NanoSig's Conference, "Big Business: Bridging Commercial Applications in Nano-Bio Technology," on Thursday, February 26, 2004. The conference features technology development at the interface of nanotechnology and biotechnology and is being held at the UCSD Connect facility in La Jolla, CA.
Biophan is using nanomagnetic particle technologies as a solution to MRI image artifacts and MRI heating of biomedical devices, which keeps millions of people from benefiting from MRI scans. Biophan has demonstrated reduced image artifacts of implantable devices (such as pacemaker leads) and minimally invasive tools (such as guidewires and catheters) and reduced device heating using nanomagnetic thin film coatings. Biophan recently announced its new NanoView(TM) technology which will utilize nanomagnetic particles as contrast agents that preferentially bind to tissues of diagnostic interest, creating improved detail and contrast in images. NanoView is intended to improve signal intensity and permit the use of multiple markers.
Biophan CEO Michael Weiner will describe how Biophan learned about research being conducted at Alfred University by Professor Xingwu Wang, and decided to invest in developing this technology. Biophan is working with Dr. Wang's company, Nanoset, LLC, which was established to commercialize several of Dr. Wang's inventions. Nanoset has two issued U.S. patents, two more have been allowed and will issue soon, and another twelve are pending. Biophan holds the worldwide exclusive rights to these patents for all medical applications. Mr. Weiner will outline other nanotechnology capabilities that may soon impact the biomedical device industry.